Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04112407
Other study ID # 5316
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 10, 2019
Est. completion date December 31, 2022

Study information

Verified date August 2023
Source Albany Medical College
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cutibacterium acnes - formally known as Propionibacter acnes (P. acnes) is the most common pathogen associated with prosthetic joint infection of the shoulder. Despite current skin preparation techniques, P. acnes is encountered at the skin surface and at the natural reservoir in the sebaceous glands during the surgical exposure; current levels of exposure are implicated in overall prosthetic infection risk. Therefore, this study endeavors to decrease P. acnes burden at the surgical incision using preoperative blue light phototherapy and benzyl peroxide washes targeting both the skin surface and sebaceous glands.


Description:

The study hypotheses will be tested using a prospective randomized-controlled trial of the effect of combination blue spectrum phototherapy and benzoyl peroxide on P. acnes at the shoulder arthroplasty surgical site. Accordingly, it will conform to the CONSORT (Consolidated Standards of Reporting Trials) guidelines. Subjects presenting to our Orthopaedic department will be randomized to one of three study arms: 1. Control: standard preparation of the surgical site without P. acnes pretreatment 2. BPO group: Pretreatment with 2 days of washes prior to surgery 3. BPO and Phototherapy: 2 days of washes with 3 treatments of blue spectrum phototherapy Patients will be seen at our office will be consented and recruited into the study. Subjects will have standard of care evaluation including: radiographs, preoperative labs and clearances. If selected and agreeable, treatment with phototherapy will involve the application of three sessions lasting 3 minutes preoperatively; the sessions will be conducted by the patient at home for two days prior to surgery and in the preoperative holding area. During each application, protective eyewear will be used. For patients in the BPO groups, a 10% benzoyl peroxide wash will be used globally on the operative shoulder and axilla during showering. An educational leaflet will outline the surgical field in addition to temporary demarcation at the time of BPO pickup at the office. Additional tests, imaging or procedures will be at the discretion of the treating physician and documented during the study. During the postoperative visit at 10-14 days, the post operative wound will be assessed in the standard manner. Final culture results will be recorded for each patient and documented in the study database. - The surgical site will be prepared in usual fashion with Chloroprep and the patients will receive preoperative Cefazolin (or vancomycin based on penicillin allergy) - Following both draping and skin incision, the surgeons gloves will be changed; any blades used in the skin incision will also be discarded - Intraoperative cultures will be taken following established protocols, published in the literature: an excisional biopsy 1cm long and 3mm wide will be taken from the medial wound edge at the time of incision; the superficial dermal tissue will be swabbed immediately after the biopsy is taken and finally, a swab of the glenohumeral (shoulder) joint will be performed prior to closure at the end of the procedure and after insertion of the implant. - Specimens will be transported to the laboratory adjoining the operating room at our institution within 1 hour of harvesting and processed by microbiology technicians in a laminar flow biological safety hood. Tissue from the skin edge will be homogenized in sterile saline solution and plated on media: blood agar, chocolate agar, Brucella agar, MacConkey agar, Columbia nalidixic acid agar and phenylethyl alcohol anaerobic blood agar. All media will be incubated at 37C for 14 days. - Specimens will be incubated for 14 days in aerobic and anaerobic media to detect P acnes and other organisms - Culture results will not be discussed with patients; patients will be consented to not know their results as they are not clinically significant - Prophylactic antibiotic treatment of positive cultures will not be performed in any case.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date December 31, 2022
Est. primary completion date December 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria - All patients presenting to the practice that require a shoulder arthroplasty procedure - English fluency and literacy - Able to provide informed consent - Older than 18 years of age - Surgical indications including: primary arthritis, rotator cuff arthropathy, post-traumatic arthritis - Primary total shoulder, hemiarthroplasty, primary reverse total shoulder or shoulder resurfacing Exclusion Criteria - Subjects who have had a prior infection of the affected shoulder joint - Recent steroid injection to the shoulder in the past 6 months - Previous open or arthroscopic procedure of the shoulder joint - Recent antibiotic use (within 90 days) - Prisoners

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Blue Light Phototherapy
Phototherapy in the blue light spectrum
Drug:
Benzyl Peroxide
Benzyl peroxide wash to be used preoperatively during showering to the operative shoulder site.
Other:
Control
Standard surgical site preparation with no P. acnes pretreatment

Locations

Country Name City State
United States Albany Medical Center Albany New York
United States Hospital for Special Surgery New York New York

Sponsors (2)

Lead Sponsor Collaborator
Albany Medical College Hospital for Special Surgery, New York

Country where clinical trial is conducted

United States, 

References & Publications (12)

Ash C, Dubec M, Donne K, Bashford T. Effect of wavelength and beam width on penetration in light-tissue interaction using computational methods. Lasers Med Sci. 2017 Nov;32(8):1909-1918. doi: 10.1007/s10103-017-2317-4. Epub 2017 Sep 12. — View Citation

Canavan TN, Chen E, Elewski BE. Optimizing Non-Antibiotic Treatments for Patients with Acne: A Review. Dermatol Ther (Heidelb). 2016 Dec;6(4):555-578. doi: 10.1007/s13555-016-0138-1. Epub 2016 Aug 19. — View Citation

Dai T, Gupta A, Murray CK, Vrahas MS, Tegos GP, Hamblin MR. Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond? Drug Resist Updat. 2012 Aug;15(4):223-36. doi: 10.1016/j.drup.2012.07.001. Epub 2012 Jul 28. — View Citation

Falconer TM, Baba M, Kruse LM, Dorrestijn O, Donaldson MJ, Smith MM, Figtree MC, Hudson BJ, Cass B, Young AA. Contamination of the Surgical Field with Propionibacterium acnes in Primary Shoulder Arthroplasty. J Bone Joint Surg Am. 2016 Oct 19;98(20):1722- — View Citation

Frangiamore SJ, Saleh A, Grosso MJ, Alolabi B, Bauer TW, Iannotti JP, Ricchetti ET. Early Versus Late Culture Growth of Propionibacterium acnes in Revision Shoulder Arthroplasty. J Bone Joint Surg Am. 2015 Jul 15;97(14):1149-58. doi: 10.2106/JBJS.N.00881. — View Citation

Kawada A, Aragane Y, Kameyama H, Sangen Y, Tezuka T. Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation. J Dermatol Sci. 2002 Nov;30(2):129-35. doi: 10.1016/s0923-1811(02)00068-3. — View Citation

Kolakowski L, Lai JK, Duvall GT, Jauregui JJ, Dubina AG, Jones DL, Williams KM, Hasan SA, Henn RF 3rd, Gilotra MN. Neer Award 2018: Benzoyl peroxide effectively decreases preoperative Cutibacterium acnes shoulder burden: a prospective randomized controlle — View Citation

Lee MJ, Pottinger PS, Butler-Wu S, Bumgarner RE, Russ SM, Matsen FA 3rd. Propionibacterium persists in the skin despite standard surgical preparation. J Bone Joint Surg Am. 2014 Sep 3;96(17):1447-50. doi: 10.2106/JBJS.M.01474. — View Citation

Oplander C, Hidding S, Werners FB, Born M, Pallua N, Suschek CV. Effects of blue light irradiation on human dermal fibroblasts. J Photochem Photobiol B. 2011 May 3;103(2):118-25. doi: 10.1016/j.jphotobiol.2011.02.018. Epub 2011 Feb 26. — View Citation

Pottinger P, Butler-Wu S, Neradilek MB, Merritt A, Bertelsen A, Jette JL, Warme WJ, Matsen FA 3rd. Prognostic factors for bacterial cultures positive for Propionibacterium acnes and other organisms in a large series of revision shoulder arthroplasties per — View Citation

Rao AJ, Chalmers PN, Cvetanovich GL, O'Brien MC, Newgren JM, Cole BJ, Verma NN, Nicholson GP, Romeo AA. Preoperative Doxycycline Does Not Reduce Propionibacterium acnes in Shoulder Arthroplasty. J Bone Joint Surg Am. 2018 Jun 6;100(11):958-964. doi: 10.21 — View Citation

Saltzman MD, Nuber GW, Gryzlo SM, Marecek GS, Koh JL. Efficacy of surgical preparation solutions in shoulder surgery. J Bone Joint Surg Am. 2009 Aug;91(8):1949-53. doi: 10.2106/JBJS.H.00768. — View Citation

* Note: There are 12 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of total culture positivity during shoulder arthroplasty To compare the rates of P. Acnes culture positivity (including all samples) between groups. Therein, assessing the efficacy of the interventions to decrease P. Acnes burden (measured by the rate of culture positivity) in surgical field. 14 days in culture
Secondary Correlation of the rate of superficial culture positivity and the rate deep culture positivity during shoulder arthroplasty To investigate the correlation between the rate of positive deep cultures in samples taken at the end of surgery (1 deep swab) and the rate of superficial culture positivity of samples taken at the beginning of the case (incisional biopsy and superficial dermal swab). It is theorized that P. Acnes in the superficial wound is propagated to the deeper tissues during surgery, impacting deep culture rates and possibly contributing to prosthetic joint infection risk. 14 days in culture
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05965986 - Preoperative Rehabilitation and Education Program N/A
Completed NCT05020821 - Superior Trunk Block Catheter Versus Single-shot Superior Trunk Block With Intravenous Dexmedetomidine for Shoulder Arthroplasty N/A
Completed NCT05350319 - Prospective Low Dose CT for Total Shoulder Arthroplasty/Reverse Shoulder Arthroplasty
Terminated NCT03845894 - Interscalene Block With Liposomal Bupivacaine vs. Interscalene Block With Bupivacaine and Adjuvants Phase 4
Recruiting NCT05699031 - Shoulder Prosthesis Telerehab Care Trial N/A
Completed NCT04822610 - Comparison of Interscalene Block and Suprascapular With Axillary Block N/A
Terminated NCT03880955 - A Post-Market Clinical Evaluation of the ReUnion Reverse Shoulder Arthroplasty (RSA) System
Terminated NCT03858517 - A Post-Market Clinical Evaluation of the ReUnion TSA System
Recruiting NCT03511586 - Total Shoulder Arthroplasty Multi-Center Registry
Recruiting NCT03268837 - Programmed Intermittent Bolus During Continuous Interscalene Nerve Block for Shoulder Arthroplasty N/A
Active, not recruiting NCT06281574 - What Are the Determinants for RTW After SA
Completed NCT05179941 - Subscapularis Indocyanine Green Perfusion Pilot Study N/A
Completed NCT03578237 - Cryoanalgesia to Prevent Acute and Chronic Pain Following Surgery: A Randomized, Double-Masked, Sham-Controlled Study N/A
Recruiting NCT00527839 - Hospital for Special Surgery Shoulder Arthroplasty Cohort